Beckman Coulter Profit Falls on Higher Costs
From Reuters
Beckman Coulter Inc. said its second-quarter profit fell on higher expenses and a decline in sales in Japan and China.
The Fullerton maker of laboratory equipment, genetic testing kits and products used in drug discovery posted net income of $44.6 million, or 70 cents a share, down from $55.2 million, or 85 cents, a year ago. Sales fell to $616.3 million from $618.8 million last year.
Beckman revised its outlook downward for the rest of the year to reflect slow growth in Asia.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
